- KALA BIO Inc at HC Wainwright Ophthalmology Virtual Conference - Pre Recorded TranscriptAug 16, 2023
- Kala Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q2 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2022$16.4 (-5.75%)Earnings
- Q1 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 16, 2022$37.08 (+8.47%)Earnings
- Q4 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 29, 2022$75 (-14.29%)Earnings
- Q3 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 15, 2021$105 (+1.45%)Earnings
- Q2 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$159 (-5.07%)Earnings
- Kala Pharmaceuticals Inc at BofA Securities 2021 Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021$297.5 (-7.75%)Earnings
- Q4 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021$386.75 (-13.38%)Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$363 (+0.14%)Earnings
- Kala Pharmaceuticals, Inc. - Special Call TranscriptOct 27, 2020
- Kala Pharmaceuticals, Inc. - Special Call TranscriptSep 17, 2020
- Q2 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020$458.5Earnings
- Kala Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020$592.5 (+1.98%)Earnings
- Kala Pharmaceuticals Inc STRIDE 3 Data Conference Call TranscriptMar 09, 2020
- Q4 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 12, 2020$313.5 (-1.95%)Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019$185.5 (-3.39%)Earnings
- Q2 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019$219 (-13.27%)Earnings
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2019$347 (-2.25%)Earnings
- Q4 2018 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 11, 2019Earnings
Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Good afternoon. This is Bill Maughan. I'm an associate on the SMid-cap Biotech Research Team here at Bank of America. And it's my pleasure to introduce our next presenter, Mark Iwicki, CEO of Kala Pharmaceuticals. Mark?
Thank you very much. And hello, everyone. I'm the CEO of Kala and I want to thank you for joining the call this afternoon. Before getting started, I want to let everyone know that we will make forward-looking statements and all information in this presentation is as of May 13, 2020, and should not be considered current after such date.
So just moving to Slide 3, Kala was formed about 10 years ago based on our AMPPLIFY technology that lets us enhance delivery to target tissues in the eye. We have IP protection for the AMPPLIFY technology and products through at least 2033. Our product that we will spend a lot of time talking about today is EYSUVIS and that is our dry eye product that has the potential to become the preferred first line prescription
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)